623
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2006
Study Completion Date
June 30, 2006
sumatriptan succinate/naproxen sodium
comparator
placebo
placebo to match
GSK Investigational Site, New York
GSK Investigational Site, The Bronx
GSK Investigational Site, Valley Stream
GSK Investigational Site, Plainview
GSK Investigational Site, Albany
GSK Investigational Site, Rochester
GSK Investigational Site, Philadelphia
GSK Investigational Site, Greensboro
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Raleigh
GSK Investigational Site, Anderson
GSK Investigational Site, Decatur
GSK Investigational Site, Rome
GSK Investigational Site, Atlanta
GSK Investigational Site, South Daytona
GSK Investigational Site, Pembroke Pines
GSK Investigational Site, Miami
GSK Investigational Site, Stuart
GSK Investigational Site, Tuscaloosa
GSK Investigational Site, Anniston
GSK Investigational Site, Clarksville
GSK Investigational Site, Bristol
GSK Investigational Site, Memphis
GSK Investigational Site, Westerville
GSK Investigational Site, West Chester
GSK Investigational Site, Concinnati
GSK Investigational Site, Evansville
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Saint Louis Park
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Hot Springs
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Antonio
GSK Investigational Site, Boulder
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Mesa
GSK Investigational Site, Albuquerque
GSK Investigational Site, Oceanside
GSK Investigational Site, San Diego
GSK Investigational Site, San Diego
GSK Investigational Site, Irvine
GSK Investigational Site, Salem
GSK Investigational Site, Eugene
GSK Investigational Site, Seattle
GSK Investigational Site, Tacoma
GSK Investigational Site, Wenatchee
GSK Investigational Site, Avon
GSK Investigational Site, Moorestown
Lead Sponsor
GlaxoSmithKline
INDUSTRY